Laurel Wealth Advisors LLC Eli Lilly & CO Transaction History

Laurel Wealth Advisors LLC

$585 Million
Q1 2024

A detailed history of Laurel Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 17,344 shares of LLY stock, worth $15.7 Million. This represents 2.31% of its overall portfolio holdings.

Number of Shares

17,344

Previous 17,678 1.89%

Holding current value

$15.7 Million

Previous $10.3 Million 30.94%

% of portfolio

2.31%

Previous 1.96%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $197,794 - $264,621	-334 Reduced 1.89%	17,344 $13.5 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $251,040 - $295,944	-478 Reduced 2.63%	17,678 $10.3 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $732,034 - $1.01 Million	-1,684 Reduced 8.49%	18,156 $9.75 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $384,411 - $514,002	-1,096 Reduced 5.24%	19,840 $9.3 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $133,570 - $156,872	430 Added 2.1%	20,936 $7.19 Million

Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $127,012 - $147,994	-395 Reduced 1.89%	20,506 $7.5 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $44,472 - $50,680	-150 Reduced 0.71%	20,901 $6.76 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $34,841 - $40,908	-125 Reduced 0.59%	21,051 $6.83 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $90,825 - $112,872	-387 Reduced 1.79%	21,176 $6.06 Million
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $47,218 - $58,598	-210 Reduced 0.96%	21,563 $5.96 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $88,418 - $108,811	-399 Reduced 1.8%	21,773 $5.03 Million
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $64,095 - $82,906	-355 Reduced 1.58%	22,172 $5.09 Million
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $84,953 - $109,976	-517 Reduced 2.24%	22,527 $4.21 Million
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $23,482 - $31,073	180 Added 0.79%	23,044 $3.89 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $72,378 - $83,719	495 Added 2.21%	22,864 $3.38 Million
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $31,513 - $37,925	-231 Reduced 1.02%	22,369 $3.67 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $21,429 - $26,523	-180 Reduced 0.79%	22,600 $3.14 Million
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $5,987 - $7,416	56 Added 0.25%	22,780 $2.99 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $7,582 - $8,247	71 Added 0.31%	22,724 $2.54 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $19,499 - $22,760	176 Added 0.78%	22,653 $2.51 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $41,629 - $49,001	-374 Reduced 1.64%	22,477 $2.92 Million
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $2.42 Million - $2.71 Million	22,851 New	22,851 $2.64 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors LLC with notifications on news.

Account

Laurel Wealth Advisors LLC Eli Lilly & CO Transaction History